Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinandos Skoulidis

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2020
Transcription Strikes Back: Clinical Utility of Lung Adenocarcinoma SubtypesFerdinandos Skoulidis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2016
Personalized Medicine Tackles Clinical Resistance: Alectinib in ALK-Positive Non-Small Cell Lung Cancer Progressing on First-Generation ALK InhibitorFerdinandos Skoulidis, Vassiliki A Papadimitrakopoulou
Nature Reviews. Cancer|August 14, 2019
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapyFerdinandos Skoulidis, John V Heymach
Cancer Cell|May 8, 2026
RAS-ing the bar in the treatment of KRAS-mutant cholangiocarcinomaMinh Truong Do, Ferdinandos Skoulidis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2016
Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung CancerFerdinandos Skoulidis, Vassiliki A Papadimitrakopoulou
Cancer Cell|October 11, 2022
A STING operation to expose KRAS and STK11 co-mutated lung cancersFerdinandos Skoulidis, John V Heymach, Tina Cascone
Molecular Cancer Therapeutics|February 4, 2011
Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressorHiroyoshi Hattori, Ferdinandos Skoulidis, Paul Russell, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2005
Ma huang associated acute liver failure requiring liver transplantationFerdinandos Skoulidis, Graeme J M Alexander, Susan E Davies
Lung Cancer (Amsterdam, Netherlands)|May 29, 2026
First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet needFabrice Barlesi, Ferdinandos Skoulidis, Benjamin Solomon, et al.
Lung Cancer (Amsterdam, Netherlands)|September 8, 2023
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testingTony Kiat Hon Lim, Ferdinandos Skoulidis, Keith M Kerr, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2020
Transcription Strikes Back: Clinical Utility of Lung Adenocarcinoma SubtypesFerdinandos Skoulidis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2016
Personalized Medicine Tackles Clinical Resistance: Alectinib in ALK-Positive Non-Small Cell Lung Cancer Progressing on First-Generation ALK InhibitorFerdinandos Skoulidis, Vassiliki A Papadimitrakopoulou
Nature Reviews. Cancer|August 14, 2019
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapyFerdinandos Skoulidis, John V Heymach
Cancer Cell|May 8, 2026
RAS-ing the bar in the treatment of KRAS-mutant cholangiocarcinomaMinh Truong Do, Ferdinandos Skoulidis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2016
Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung CancerFerdinandos Skoulidis, Vassiliki A Papadimitrakopoulou
Cancer Cell|October 11, 2022
A STING operation to expose KRAS and STK11 co-mutated lung cancersFerdinandos Skoulidis, John V Heymach, Tina Cascone
Molecular Cancer Therapeutics|February 4, 2011
Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressorHiroyoshi Hattori, Ferdinandos Skoulidis, Paul Russell, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2005
Ma huang associated acute liver failure requiring liver transplantationFerdinandos Skoulidis, Graeme J M Alexander, Susan E Davies
Lung Cancer (Amsterdam, Netherlands)|May 29, 2026
First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet needFabrice Barlesi, Ferdinandos Skoulidis, Benjamin Solomon, et al.
Lung Cancer (Amsterdam, Netherlands)|September 8, 2023
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testingTony Kiat Hon Lim, Ferdinandos Skoulidis, Keith M Kerr, et al.
Pageof 8